Evaxion AS (EVAX)
4.11
+0.19
(+4.85%)
USD |
NASDAQ |
May 18, 11:20
Evaxion EPS Diluted (Quarterly) : -0.4366 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ascendis Pharma A/S | 11.41 |
| DBV Technologies SA | -0.5577 |
| Cellectis SA | -0.1774 |
| Akari Therapeutics Plc | 0.00 |
| Biodexa Pharmaceuticals Plc | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.642M |
| Total Expenses (Quarterly) | 3.642M |
| Enterprise Value | 14.25M |
| Earnings Yield | -33.64% |
| Normalized Earnings Yield | -33.64 |